electroCore, Inc. (ECOR) vs MaxCyte, Inc. (MXCT)
electroCore, Inc. and MaxCyte, Inc. are both Medical Devices companies. MaxCyte, Inc. is the larger, with a market value of $122.8M against $102.3M — 1.2× the size. electroCore, Inc. grew revenue faster over the last twelve months: 33.5% against −13.2%. electroCore, Inc. has the higher net margin (−40.0% vs −114.8%) and the higher return on invested capital (0.00% vs −49.2%). Across the 17 metrics below, electroCore, Inc. leads on 14 and MaxCyte, Inc. on 3.
Valuation
Profitability
| Metric | ECOR | MXCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.06% | 79.23% | 56.01% |
| Operating margin | (37.64%) | (134.59%) | (15.03%) |
| Net margin | (39.96%) | (114.77%) | (20.40%) |
| Free cash flow margin | (26.36%) | (76.14%) | (7.24%) |
| Return on equity | 1,761.48% | (20.39%) | (15.32%) |
| Return on assets | (93.41%) | (17.62%) | (19.72%) |
| Return on invested capital | 0.00% | (49.23%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack